|
2024
|
Invention
|
Methods for treating alcohol addiction, alcohol-use disorders and alcohol-related inflammatory di... |
|
|
Invention
|
Pharmaceutical compositions, and preparation and methods of use thereof |
|
|
Invention
|
Pharmaceutical compositions, and preparation and methods of use thereof. The invention relates to... |
|
|
Invention
|
Compounds for treating cannabinoid toxicity and acute cannabinoid overdose.
The present inventio... |
|
2023
|
Invention
|
Pharmaceutical compositions, and preparation and methods of use thereof.
The invention relates t... |
|
2021
|
Invention
|
Compounds for treating cannabinoid toxicity and acute cannabinoid overdose. 9-tetrahydrocannabino... |
|
|
Invention
|
Novel compounds for treating fibrosis and inflammatory conditions.
Several biological targets ha... |
|
|
Invention
|
Novel compounds for treating fibrosis and inflammatory conditions. Several biological targets hav... |
|
|
Invention
|
Process for making biologically active compounds and intermediates thereof. A process of manufact... |
|
|
Invention
|
Process for making biologically active compounds and intermediates thereof. A process of ma... |
|
2018
|
Invention
|
Abhd6 and dual abhd6/mgl inhibitors and their uses. Provided herein are compounds and pharmaceuti... |
|
2015
|
Invention
|
Method for treating a neurodegenerative event.
A method of neuroprotection or treating or healin... |
|
2012
|
Invention
|
Cb1 receptor antagonists and uses thereof.
Neutral antagonists of the CB1 cannabinoid receptor, ... |
|
2008
|
Invention
|
Cb1 receptor antagonists and uses thereof. Neutral antagonists of the CB1 cannabinoid receptor, m... |
|
2003
|
Invention
|
Antiprotozoal ring-substituted phospholipids. 3—W and physiologically acceptable salts thereof an... |
|
|
Invention
|
Antiprotozoal ring-substituted phospholipids.
Disclosed are novel ring containing phos... |
